What is Cystic Fibrosis (CF)?

Cystic Fibrosis is a genetic disorder that primarily affects the lungs and digestive system, causing mucus buildup and respiratory and digestive problems.

How big is the Cystic-Fibrosis Therapeutics Market?

The global Cystic-Fibrosis Therapeutics Market size was estimated at USD 9.7 Billion in 2023 and is expected to reach USD 25.4 Billion in 2033.

What is the Cystic-Fibrosis Therapeutics Market growth?

The global Cystic-Fibrosis Therapeutics Market is expected to grow at a compound annual growth rate of 9.0%. From 2024 To 2033

Who are the key companies/players in the Cystic-Fibrosis Therapeutics Market?

Some of the key players in the Cystic-Fibrosis Therapeutics Markets are AbbVie, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Vertex Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Alcresta Therapeutics, Inc., Allergan, AstraZeneca., Other Key Players.

What drives the growth of the CF Therapeutics Market?

The market is driven by advancements in treatments, rising CF prevalence, and personalized medicine approaches.

What are CFTR modulators?

CFTR modulators are a class of drugs that target the underlying genetic defect in CF and improve lung function and quality of life.

What are the key distribution channels for CF therapeutics?

Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies are the primary distribution channels for CF medications.

Global Cystic-Fibrosis Therapeutics Market By Drug Class(Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), Pancreatic Enzyme Supplement, Bronchodilators, Other Drug Classes) By Route of Administration(Oral, Parenteral) By Distribution Channel(Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: July 2024
Report ID: 78573
Number of Pages: 245
Format:

- AbbVie, Inc.
- F. Hoffmann-La Roche Ltd.
- Novartis AG Company Profile
- Vertex Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd. Company Profile
- Merck & Co., Inc.
- Alcresta Therapeutics, Inc.
- Allergan
- AstraZeneca.
- Other Key Players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 78573
Published Date July 2024
Rating
- ★★★★★
  
  ★★★★★
- (22)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)